40
Participants
Start Date
August 31, 2008
Primary Completion Date
June 30, 2011
Study Completion Date
August 31, 2012
Exenatide
0.05 µg/min bolus of open-label exenatide followed by a constant infusion of 0.025 µg/min for 24-48 hours
Mid America Heart Institute Saint Luke's Health System, Kansas City
Collaborators (1)
Amylin Pharmaceuticals, LLC.
INDUSTRY
Saint Luke's Health System
OTHER